LOADING
Comparing Microsoft Corporation (MSFT) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | MRK |
|---|---|---|
| Price | $424.13 | $111.81 |
| Change Today | +3.59% | -1.41% |
| Market Cap | $3.01T | $280.2B |
| P/E Ratio | 24.1 | 32.0 |
| Forward P/E | 21.5 | 22.0 |
| PEG Ratio | 1.29 | 5.18 |
| EPS | $16.78 | $3.55 |
| Revenue Growth (YoY) | 18.3% | 4.9% |
| Profit Margin | 39.3% | 13.6% |
| Return on Equity | 34.0% | 18.9% |
| Dividend Yield | 0.87% | 2.92% |
| Beta | 1.09 | 0.20 |
| 52-Week High | $552.24 | $124.22 |
| 52-Week Low | $356.28 | $71.76 |
| Volume | 318K | 58K |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.